Author Archive for: Paul Schellhammer

About Paul Schellhammer

This author has yet to write their bio.
Meanwhile lets just say that we are proud Paul Schellhammer contributed a whooping 1 entries.

Entries by

Editorial: Oestrogen redux: will transdermal delivery rebalance the risk–benefit equation?

Between 1960 and 1975, the Veterans Association Cooperative Urological Research Group (VACURG) conducted a series of large randomized trials to test several oestrogenic compounds in varying doses and combinations with regard to their efficacy and safety in the treatment of all stages of prostate cancer [1]. The major message conveyed by these trials was the […]

© 2020 BJU International. All Rights Reserved.